Prime Medicine, Inc. PRME 深 滬
已收盤 08-01 16:00:00 美东时间
4.04
+0.300
+8.02%
華盛通- 最 高4.07
- 今 開3.51
- 成交量 474.46万股
- 最 低 3.51
- 昨 收 3.74
- 總市值 3.81亿
- 52周最高 5.17
- 市盈率 靜 --
- 換手率 5.03%
- 52周最低 1.11
- 委 比 74.71%
- 總股本 9433.60万
- 歷史最高 21.73
- 量 比 1.22
- 振 幅 14.97%
- 歷史最低 1.11
- 每 手 1
- 風險率 1.08%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Prime Medicine, a biotechnology company, closed an underwritten public offering of 43.7 million shares at $3.30 per share, raising approximately $144.2 million. The offering included the full exercise of the underwriters’ option to purchase additional shares and utilized an effective shelf registration statement. The funds will support the company’s efforts in developing gene editing therapies using its Prime Editing platform.
08-01 20:01
Prime Medicine slides after pricing $125.4M stock offering
Prime Medicine (NASDAQ:PRME) has priced its public offering of 38 million shares at $3.30 each, aiming to raise about $125.4 million before expenses. The company has also given underwriters a 30-day o...
07-31 11:51
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers OSR Holdings (NASDAQ:OSRH) stock rose 21.4% to $1.05 during Wednesday'...
07-31 05:06
Prime Medicine Halts Sales Agreement Prospectus
Prime Medicine, Inc. ( ($PRME) ) has provided an update. On July 30, 2025, Prim...
07-31 04:50
Prime Medicine Announces Proposed Public Offering Of Common Stock; No Size Or Amount Disclosed
Prime Medicine, Inc. (NASDAQ:PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that it has commenced an underwritten public offering
07-31 04:21
Prime Medicine Announces Pricing of Public Offering
Prime Medicine (NASDAQ: PRME) announced the pricing of a public offering of 38 million shares at $3.30 per share, raising approximately $125.4 million before expenses. The underwriters have a 30-day option to purchase up to an additional 5.7 million shares. Proceeds will support the company’s gene editing therapies, utilizing its Prime Editing platform to develop one-time curative treatments for genetic diseases.
07-31 01:33
Galaxy Digital, Blaize Holdings, Verizon And Other Big Stocks Moving Higher On Monday
U.S. stocks were higher, with the Dow Jones index gaining around 100 points on ...
07-21 22:16
Prime Medicine soars as Jones sees it as an acquisition target
Prime Therapeutics (NASDAQ:PRME) skyrocketed ~35% Monday after JonesTrading issued a bullish report on the company due to increased interest in gene editing in the wake of Eli Lilly's (NYSE:LLY) deal ...
07-08 00:33
Prime Drink Group Announces Auditor Change
Dominion Water Reserves ( ($TSE:PRME) ) has provided an announcement. Prime Dri...
07-05 09:02
Prime Drink Group Launches $1 Million Private Placement
Dominion Water Reserves ( ($TSE:PRME) ) has shared an update. Prime Drink Group...
07-03 07:37
